Answers are grounded in this paper and cite their sources.
Pilot study shows UVC222 reduces bacterial density on breast implants and skin, suggesting its role in sterilization.
This pilot study shows that UVC222 effectively reduces bacterial density on breast implant surfaces and submammary fold epidermis, supporting its potential as an intraoperative sterilization tool. Further studies are needed to assess long-term safety and efficacy in surgical settings.
No takes yet. Share an insight, caveat, or question.
Wimmer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: